RBM10 and neoplasm: The predominantly metastatic tumours in our cohort contained more frequent mutations in several genes such as SETD2, APC, KDM5C, HIF1A, RBM10, TRAK1 and FBXW7, while we detected lower mutation rates in VHL compared to the primary tumours analysed in the TCGA study.